RecruitingPhase 2NCT05358548

ATATcH Alternating Treatment Plans for Advanced Cancer

Alternating Treatment Plans for Participants With Advanced Thoracic/Head & Neck Cancers (ATATcH)


Sponsor

Rutgers, The State University of New Jersey

Enrollment

150 participants

Start Date

Apr 28, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of the research is to evaluate a new schedule of alternating cycles of induction chemoimmunotherapy (chemotherapy plus pembrolizumab) and immunotherapy (pembrolizumab) alone for the initial treatment of patients with advanced lung or head and neck cancers.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether alternating between two different treatment plans — rather than staying on one regimen — can better control advanced lung cancer (stage IV non-small cell lung cancer) or other advanced cancers, by preventing the cancer from becoming resistant to treatment. **You may be eligible if...** - You have advanced or stage IV non-small cell lung cancer (either squamous or non-squamous) - Or you have another eligible advanced cancer type included in the study - You have not received prior treatment for metastatic disease - Your tumor has been tested for specific genetic markers - You are in good general health (adequate organ function) **You may NOT be eligible if...** - Your cancer has spread to the brain in a way that is unstable or untreated - You have active autoimmune disease - You have had prior treatments that exclude you from the study arms - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGPaclitaxel

Is a chemotherapy drug. Used to treat kinds of cancer, as determined by the doctor

DRUGPemetrexed

Is a chemotherapy drug. Used to treat kinds of cancer, as determined by the doctor

DRUG5Fluorouracil

Is a chemotherapy drug. Used to treat kinds of cancer, as determined by the doctor

DRUGCarboplatin

Is a chemotherapy drug. Used to treat kinds of cancer, as determined by the doctor

DRUGPembrolizumab

It is a type of immunotherapy and works by helping your immune system to kill cancer cells


Locations(11)

Trinitas Hospital and Comprehensive Cancer Center

Elizabeth, New Jersey, United States

Cancer Institute of New Jersey at Hamilton

Hamilton, New Jersey, United States

RWJBarnabas Health - Jersey City

Jersey City, New Jersey, United States

RWJBarnabas Health - Monmouth Medical Center Southern Campus

Lakewood, New Jersey, United States

RWJBarnabas Health - Saint Barnabas Medical Center

Livingston, New Jersey, United States

RWJBarnabas Health - Monmouth Medical Center

Long Branch, New Jersey, United States

RWJ Barnabas Health - Robert Wood Johnson University Hospital

New Brunswick, New Jersey, United States

Rutgers Cancer Institute of New Jersey

New Brunswick, New Jersey, United States

RWJBarnabas Health - Newark Beth Israel Medical Center

Newark, New Jersey, United States

Robert Wood Johnson Somerset Hospital

Somerville, New Jersey, United States

RWJBarnabas Health - Community Medical Center

Toms River, New Jersey, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05358548


Related Trials